Mycobacterial Metabolic Syndrome: LprG and Rv1410 Regulate Triacylglyceride Levels, Growth Rate and Virulence in Mycobacterium tuberculosis

Amanda J. Martinot(Harvard University), Mary F. Farrow(Harvard University), Lu Bai(Stony Brook University), Emilie Layre(Harvard University), Tan‐Yun Cheng(Brigham and Women's Hospital), Jennifer Tsai(Texas A&M University), Jahangir Iqbal(SUNY Downstate Health Sciences University), John W. Annand(Brigham and Women's Hospital), Zuri A. Sullivan(Harvard University), M. Mahmood Hussain(SUNY Downstate Health Sciences University), James C. Sacchettini(Texas A&M University), D. Branch Moody(Harvard University), Jessica C. Seeliger(Stony Brook University), Eric J. Rubin(Harvard University)
PLoS Pathogens
January 11, 2016
Cited by 103Open Access
Full Text

Abstract

Mycobacterium tuberculosis (Mtb) mutants lacking rv1411c, which encodes the lipoprotein LprG, and rv1410c, which encodes a putative efflux pump, are dramatically attenuated for growth in mice. Here we show that loss of LprG-Rv1410 in Mtb leads to intracellular triacylglyceride (TAG) accumulation, and overexpression of the locus increases the levels of TAG in the culture medium, demonstrating a role of this locus in TAG transport. LprG binds TAG within a large hydrophobic cleft and is sufficient to transfer TAG from donor to acceptor membranes. Further, LprG-Rv1410 is critical for broadly regulating bacterial growth and metabolism in vitro during carbon restriction and in vivo during infection of mice. The growth defect in mice is due to disrupted bacterial metabolism and occurs independently of key immune regulators. The in vivo essentiality of this locus suggests that this export system and other regulators of metabolism should be considered as targets for novel therapeutics.


Related Papers

No related papers found

Powered by citation graph analysis